Home/Filings/4/0000899243-20-031770
4//SEC Filing

Versant Side Fund IV, L.P. 4

Accession 0000899243-20-031770

CIK 0001531048other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 9:18 PM ET

Size

16.0 KB

Accession

0000899243-20-031770

Insider Transaction Report

Form 4
Period: 2020-11-17
Transactions
  • Other

    Common Stock

    2020-11-173,004,4152,705,162 total(indirect: See footnote)
  • Other

    Common Stock

    2020-11-17164,8250 total(indirect: See footnote)
  • Other

    Common Stock

    2020-11-17+164,825164,825 total(indirect: See footnote)
  • Other

    Common Stock

    2020-11-1718,92517,040 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2020-11-1718,92517,040 total(indirect: See footnote)
  • Other

    Common Stock

    2020-11-173,004,4152,705,162 total(indirect: See footnote)
  • Other

    Common Stock

    2020-11-17+164,825164,825 total(indirect: See footnote)
  • Other

    Common Stock

    2020-11-17164,8250 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2020-11-173,004,4152,705,162 total(indirect: See footnote)
  • Other

    Common Stock

    2020-11-17164,8250 total(indirect: See footnote)
  • Other

    Common Stock

    2020-11-17+164,825164,825 total(indirect: See footnote)
  • Other

    Common Stock

    2020-11-1718,92517,040 total(indirect: See footnote)
Footnotes (7)
  • [F1]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital IV, L.P. ("Versant IV"), to its partners, pursuant to a Rule 10b5-1 distribution plan.
  • [F2]Shares held by Versant IV. Versant Ventures IV, LLC ("Versant Ventures IV GP") is the general partner of Versant IV. Kirk G. Nielsen is a managing member of Versant Ventures IV GP and may be deemed to share voting and dispositive power over the shares held by Versant IV; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Kirk G. Nielsen is a director of the Issuer and, accordingly, files separate Section 16 reports.
  • [F3]Represents a change in the form of ownership of Versant Ventures IV GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant IV.
  • [F4]Shares held by Versant Ventures IV GP. Kirk G. Nielsen is a managing member of Versant Ventures IV GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Kirk G. Nielsen is a director of the Issuer and, accordingly, files separate Section 16 reports.
  • [F5]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures IV GP to its members.
  • [F6]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund IV, L.P. ("Versant Side Fund"), to its partners, pursuant to a Rule 10b5-1 distribution plan.
  • [F7]Shares held by Versant Side Fund. Versant Ventures IV GP is the general partner of Versant Side Fund. Kirk G. Nielsen is a managing member of Versant Ventures IV GP and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Kirk G. Nielsen is a director of the Issuer and, accordingly, files separate Section 16 reports.

Issuer

Inari Medical, Inc.

CIK 0001531048

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001456591

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 9:18 PM ET
Size
16.0 KB